BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31200327)

  • 1. Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma.
    Ohashi R; Schraml P; Batavia A; Angori S; Simmler P; Rupp N; Ajioka Y; Oliva E; Moch H
    Transl Oncol; 2019 Sep; 12(9):1131-1137. PubMed ID: 31200327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability.
    Paolella BR; Gibson WJ; Urbanski LM; Alberta JA; Zack TI; Bandopadhayay P; Nichols CA; Agarwalla PK; Brown MS; Lamothe R; Yu Y; Choi PS; Obeng EA; Heckl D; Wei G; Wang B; Tsherniak A; Vazquez F; Weir BA; Root DE; Cowley GS; Buhrlage SJ; Stiles CD; Ebert BL; Hahn WC; Reed R; Beroukhim R
    Elife; 2017 Feb; 6():. PubMed ID: 28177281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype.
    Ohashi R; Schraml P; Angori S; Batavia AA; Rupp NJ; Ohe C; Otsuki Y; Kawasaki T; Kobayashi H; Kobayashi K; Miyazaki T; Shibuya H; Usuda H; Umezu H; Fujishima F; Furusato B; Osakabe M; Sugai T; Kuroda N; Tsuzuki T; Nagashima Y; Ajioka Y; Moch H
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients.
    Ohashi R; Angori S; Batavia AA; Rupp NJ; Ajioka Y; Schraml P; Moch H
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32079343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Cancer Gene Dependencies with Anthrax-Mediated Delivery of Peptide Nucleic Acids.
    Lu Z; Paolella BR; Truex NL; Loftis AR; Liao X; Rabideau AE; Brown MS; Busanovich J; Beroukhim R; Pentelute BL
    ACS Chem Biol; 2020 Jun; 15(6):1358-1369. PubMed ID: 32348107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
    Liu Q; Cornejo KM; Cheng L; Hutchinson L; Wang M; Zhang S; Tomaszewicz K; Cosar EF; Woda BA; Jiang Z
    Am J Pathol; 2018 Apr; 188(4):846-852. PubMed ID: 29353061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations of HER genes in chromophobe renal cell carcinoma.
    Weng WH; Chen YT; Yu KJ; Chang YH; Chuang CK; Pang ST
    Oncol Lett; 2016 Mar; 11(3):2111-2116. PubMed ID: 26998131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas.
    Sun M; Tong P; Kong W; Dong B; Huang Y; Park IY; Zhou L; Liu XD; Ding Z; Zhang X; Bai S; German P; Powell R; Wang Q; Tong X; Tannir NM; Matin SF; Rathmell WK; Fuller GN; McCutcheon IE; Walker CL; Wang J; Jonasch E
    Cancer Res; 2017 Oct; 77(19):5313-5326. PubMed ID: 28807937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abundant copy-number loss of CYCLOPS and STOP genes in gastric adenocarcinoma.
    Cutcutache I; Wu AY; Suzuki Y; McPherson JR; Lei Z; Deng N; Zhang S; Wong WK; Soo KC; Chan WH; Ooi LL; Welsch R; Tan P; Rozen SG
    Gastric Cancer; 2016 Apr; 19(2):453-465. PubMed ID: 26205786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis.
    Wu H; Fan L; Liu H; Guan B; Hu B; Liu F; Hocher B; Yin L
    Biomed Res Int; 2020; 2020():4030915. PubMed ID: 31998788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking enhanced the expression of c-kit in chromophobe renal cell carcinoma.
    Jiang J; Yang L; Chen M; Xiao F; Zeng Y; Zhu H; Li Y; Liu L
    Tob Induc Dis; 2023; 21():126. PubMed ID: 37808589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of the effects of the CYCLOPS gene RBM17 in hepatocellular carcinoma.
    Li C; Ge S; Zhou J; Peng J; Chen J; Dong S; Feng X; Su N; Zhang L; Zhong Y; Deng L; Tang X
    PLoS One; 2020; 15(6):e0234062. PubMed ID: 32497093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid oncocytic/chromophobe renal cell tumor: An integrated genetic and epigenetic characterization of a case.
    Pires-Luis A; Montezuma D; Vieira J; Ramalho-Carvalho J; Santos C; Teixeira M; Jerónimo C; Henrique R
    Exp Mol Pathol; 2018 Dec; 105(3):352-356. PubMed ID: 30343009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma.
    Casuscelli J; Weinhold N; Gundem G; Wang L; Zabor EC; Drill E; Wang PI; Nanjangud GJ; Redzematovic A; Nargund AM; Manley BJ; Arcila ME; Donin NM; Cheville JC; Thompson RH; Pantuck AJ; Russo P; Cheng EH; Lee W; Tickoo SK; Ostrovnaya I; Creighton CJ; Papaemmanuil E; Seshan VE; Hakimi AA; Hsieh JJ
    JCI Insight; 2017 Jun; 2(12):. PubMed ID: 28614790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
    Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
    Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Critical Gene Screening to Prevent Chromophobe Cell Renal Carcinoma Metastasis through TCGA and WGCNA.
    Yan C; Yang Y; Tang Y; Zheng X; Xu B
    J Oncol; 2022; 2022():2909095. PubMed ID: 36284630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of
    Wang S; Yu ZH; Chai KQ
    Oncol Lett; 2019 Aug; 18(2):1767-1774. PubMed ID: 31423244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
    Velickovic M; Delahunt B; Störkel S; Grebem SK
    Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial loss of genes might open therapeutic window.
    Liu B; Abdel-Wahab O
    Elife; 2017 Mar; 6():. PubMed ID: 28304277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.